Middle East & Africa Cancer Diagnostics Market Size & Outlook
Middle East & Africa cancer diagnostics market, 2018-2030 (US$M)
Related Markets
MEA cancer diagnostics market highlights
- The MEA cancer diagnostics market generated a revenue of USD 4,113.1 million in 2024.
- The market is expected to grow at a CAGR of 4.6% from 2025 to 2030.
- In terms of segment, private was the largest revenue generating coverage in 2024.
- Public insurance is the most lucrative coverage segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2024 | USD 4,113.1 million |
| Market revenue in 2030 | USD 5,327.7 million |
| Growth rate | 4.6% (CAGR from 2025 to 2030) |
| Largest segment | Private |
| Fastest growing segment | Public insurance |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Public insurance, Private |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.8% of the global cancer diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 31,420.2 million by 2030.
Private was the largest segment with a revenue share of 65.39% in 2024. Horizon Databook has segmented the Middle East & Africa cancer diagnostics market based on public insurance, private covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & Africa holds major growth opportunities, as a majority of the market is untapped due to the unavailability of organized cancer screening programs in this region, especially in underdeveloped African economies.
In the past few years, countries such as the UAE, Morocco, & South Africa have organized cancer screening programs. Collaborations of various companies with government institutes to supply these tests are also expected to boost the market.
These initiatives are anticipated to lead to the development of newer cancer detection tests. Novel cancer tests, including liquid biopsy, are expensive, thus, there is a shortage of experienced professionals to perform these tests.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
